Prevalence of breathlessness and its effect on quality of life in advanced cancer
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/10/037194
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 498
Inclusion Criteria
1. All patients with advanced cancer (stage IV diagnosis), referred for the first time to Department of Palliative Medicine
2. Age more than 18 years
3. Patient with normal cognitive status as determined by the physician and by her/his ability to understand the nature of the study and provide consent for the process
4. Patient willing to participate in the study and sign informed consent
Exclusion Criteria
1. Patients unable to give consent due to impaired cognition, moribund state and acute medical illness
2. Those who refuse to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome of the study is determining the prevalence of dyspnoea in advanced cancer and to describe the correlation between the intensity of dyspnoea and the QOL of patients.The primary outcome measures used are intensity of dyspnoea as per ESAS, Cancer Dyspnoea Scale, and EORTC QLQ-C15-pal Questionnaires.Timepoint: over a period of six months from the date of first enrollment
- Secondary Outcome Measures
Name Time Method The secondary outcome measures used are the demographic details of the participant, numerical rating of symptoms as per ESAS, intensity and perception of dyspnoea as per the Cancer Dyspnoea Scale, ECOG scale for functional status.Timepoint: over a period of six months from the date of first enrollment